Next Article in Journal
Is Hearing Loss a Risk Factor for Idiopathic Parkinson’s Disease? An English Longitudinal Study of Ageing Analysis
Next Article in Special Issue
Frontotemporal-TDP and LATE Neurocognitive Disorders: A Pathophysiological and Genetic Approach
Previous Article in Journal
Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Previous Article in Special Issue
Detection of Alzheimer’s Disease Using Logistic Regression and Clock Drawing Errors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Association between Pesticide Exposure and the Development of Fronto-Temporal Dementia-Cum-Dissociative Disorders: A Review

by
Carlos Alfonso Flores-Gutierrez
1,
Erandis Dheni Torres-Sanchez
1,
Emmanuel Reyes-Uribe
1,
Juan Heriberto Torres-Jasso
2,
Mireya Zoila Reyna-Villela
3,
Daniel Rojas-Bravo
3 and
Joel Salazar-Flores
1,*
1
Department of Medical and Life Sciences, Centro Universitario de la Cienega (CUCI-UdeG), University of Guadalajara, Avenida Universidad #1115, Ocotlan 47810, Jalisco, Mexico
2
Department of Biological Sciences, University Center of the Coast, University of Guadalajara (CUCos-ta-UdeG), Avenida Universidad de Guadalajara #203, Delegacion Ixtapa, Puerto Vallarta 48280, Jalisco, Mexico
3
Department of Technological Sciences, Cienega University Center (CUCI-UdeG), University of Guadalajara, Avenida Universidad #1115, Ocotlan 47810, Jalisco, Mexico
*
Author to whom correspondence should be addressed.
Brain Sci. 2023, 13(8), 1194; https://doi.org/10.3390/brainsci13081194
Submission received: 12 July 2023 / Revised: 9 August 2023 / Accepted: 11 August 2023 / Published: 12 August 2023
(This article belongs to the Special Issue New Advances in Alzheimer’s Disease and Other Associated Diseases)

Abstract

:
Pesticides are chemicals used in agricultural fields for the prevention or destruction of pests. Inappropriate use of these substances, as well as handling them without using personal protective equipment, may result in serious health problems such as neurodegenerative diseases and mental disorders. Previous studies have demonstrated the adverse effects of pesticides on brain function. However, some researchers have associated pesticide poisoning with the development of disorders such as dissociative amnesia, multiple personality disorders, and depersonalization disorder. The objective of this work was to perform a bibliographic review of the relationship between pesticide poisoning and the development of dissociative disorders. Previous studies suggest that the duration of pesticide exposure is a major determinant in the development of dissociative diseases and disorders. The information obtained in this review suggests that there is no specific relationship between dissociative disorders and pesticide poisoning. However, these results point to associating the most representative symptoms of dissociative disorder (such as amnesia and memory loss) with pesticide exposure. Based on the bibliographic search, possible mechanisms of action were suggested in an attempt to explain a possible association between exposure to pesticides and the appearance of dissociative disorders.

1. Introduction

Pesticide poisoning represents a great risk to the health of the global population. A study carried out by the ONU in 2017 showed that 200,000 deaths from poisoning are recorded annually, especially in developing countries [1]. Farmers are highly vulnerable to pesticide poisoning due to direct contact with these chemicals. Among the most widely used pesticides in the world are organophosphates (OPs), carbamates, and pyrethroids [2]. Speaking specifically of OPs, worldwide it is estimated that around 3 million people are exposed to this type of pesticide each year, which represents approximately 300,000 deaths [3].The mechanism of action of OPs is through the inhibition of acetylcholinesterase (AChE) in the synapse, which leads to an accumulation of acetylcholine (ACh) from cholinergic receptors (muscarinic and nicotinic) in the central and autonomic nervous system and in the neuromuscular junctions, causing different clinical manifestations [4]. The degree of poisoning and the symptoms manifested depend on factors such as age, sex, the pathologies of the individual, type of pesticide, as well as dose and exposure time, which determine whether the poisoning will be classified as acute or chronic. An acute exposure is generated in a short time, generally between minutes and the first 24 h, with representative symptoms such as bronchorrhoea, vomiting, diarrhea, salivation, miosis, headache, and dizziness. In contrast, chronic poisoning occurs after a long period of exposure, and it causes damage to the neurological system, oxidative stress, and immune system symptoms [5]. In addition, OPs impair the functions of serotonergic and dopaminergic neurons and the expressions of genes related to neurobehavior. Thus, exposure to these pesticides affects the central nervous system, thereby causing behavioral disorders at different stages of human development. Alterations in neurotransmitter systems affect memory-related functions and damage neural connections, leading to neurodevelopmental disorders [6].
Although pesticides produce harmful effects on the brain by triggering severe illnesses such as Parkinson’s disease, Alzheimer’s disease, and Major Cognitive Disorder, not much information is available about the link between pesticides and the development of other mental illnesses such as frontotemporal dementia and dissociative disorders. Therefore, this study was carried out with the objective of doing a review of the literature to find a possible association between exposure to pesticides and the development of these mental disorders.

1.1. Mental Disorders and Pesticide Poisoning

1.1.1. Frontotemporal Dementia (FTD)

Worldwide, it is estimated that fifty million people undergo dementia, a figure that has increased to ten million cases each year, ranking among the ten main causes of death, with a negative impact on the psychological, physical, and social level that affects the quality of life of patients and represents one of the main causes of dependency and disability [7]. The most relevant types of cortical dementias are dementia with Lewy bodies, Alzheimer’s disease, and FTD [8].
FTD is a neurodegenerative disease characterized by progressive changes in personality and behavior and/or early and progressive language impairment [9]. It is the second most common cause of dementia in people under 65 years of age [10]. Due to the heterogeneity of cognitive alterations, FTD comprises three clinical variants: behavioral/frontal, primary progressive aphasia, and semantic dementia [11]. These variants are shown in Table 1.

Front Variant

The frontal variant represents 90% of FTD cases, and it presents very varied alterations depending on the affected prefrontal area. If it affects the orbitofrontal area, it causes a lack of social sensitivity, aggressiveness, inattentiveness, and changes in personality. On the other hand, if the mesiofrontal area is affected, it results in apathy, a lack of interest, a loss of ability to move, and decreased verbal fluency. Finally, if the dorsolateral area is altered, patients are unable to make decisions, maintain attention, or remember the chronology of events [12,13]. These alterations are shown in Figure 1.

Primary Progressive Aphasia

In primary progressive aphasia, syntactic and phonological language alterations occur, which at the initial stages produce an inability to remember names of people or objects, followed by agrammatism, which may end in mutism [13]. This aphasic syndrome is divided into two variables: fluent (affects semantic processing, but syntax and phonology are preserved) and non-fluent, i.e., grammatical errors and phonological paraphasia [14,15]. In advanced stages of the disease, when all aspects of language are severely affected, memory deficits and behavioral changes may also manifest (Figure 1) [15].

Semantic Dementia

Semantic dementia is characterized by an inability to recognize facts, objects, or the meaning of words. In addition, the ability to perceive visual stimuli, smells, tastes, and non-verbal sounds is progressively lost. People with semantic dementia may present behavioral changes that are different from the frontal variant since they concentrate most of their time on a single activity in contrast to loss of interest, which is a characteristic of the frontal variant (Figure 1) [16].

Relationship FDT Variants with Pesticides

There are highly toxic pesticides for dopaminergic neurons [17]. The loss of dopamine in the connections between the prefrontal cortex and caudate nucleus leads to inhibition of response and planning. This results in the inability to sustain directed activities to achieve a set goal or objective and the inability to correctly perform motor actions associated with complex movement [18]. This may be associated with the frontal variant of FTD since if the mesiofrontal area is affected, there is loss of movement in the same way. An alteration in the dorsolateral zone leads to the inability to make decisions, which could explain the lack of planning and response due to a decrease in the level of dopamine in the connection between the prefrontal cortex and caudate nucleus [12,13,18]. It should be noted that the decrease in the amount of dopamine is also related to the use of chemical herbicides such as Paraquat, Diquat, and the fungicide MANEB, which are toxic to nigrostriatal dopaminergic neurons [17].

1.1.2. Parkinson’s Disease (PD)

PD is the second most frequent neurodegenerative disease after Alzheimer’s disease [18]. The main signs of PD are akinesia, postural rigidity, and tremor at rest, which are the consequences of impairment in dopaminergic activity. Neuronal death, mainly in the substantia nigra, leads to a reduction in dopamine levels, which is responsible for the characteristic signs of the disease. In addition, the degeneration of the substantia nigra causes deficits in balance [19]. Epidemiological data suggest that there is an increased risk of developing PD after exposure to pesticides [20]. Pesticides such as paraquat, rotenone, and dieldrin induce apoptosis of dopaminergic neurons [21].
On the other hand, the presence of α-synuclein (a protein that forms Lewy bodies) in the enteric nervous system, submandibular gland, dorsal motor nucleus of the vagus nerve, and olfactory bulb may cause these peripheral areas to act as receptors for environmental factors that trigger the onset of PD, such as the pesticides rotenone and paraquat [18]. Heiko et al. (2003) described the progression of PD in 6 stages related to the presence of α-synuclein in different locations, and its clinical correlation. Stages 1–3 correspond to the preclinical phase of the disease. At these stages, α-synuclein aggregates are found at the level of the sympathetic and parasympathetic pre- and post-ganglionic fibers of the enteric nervous system connected to the olfactory bulb, dorsal nucleus of the vagus nerve, and at the level of the spinal cord. In stage 4, there is neurodegeneration in the zona pars compacta of the substantia nigra. Finally, in stages 5–6, the α-synuclein aggregates are distributed in sensory association areas corresponding to the premotor and motor prefrontal cortex [22].
Table 2 shows different pesticides related to the development of PD. Organochlorines (dieldrin and lindane) have been associated with PD. Various studies have shown the toxic effects of dieldrin and lindane on dopaminergic neurons, resulting in ROS-induced apoptosis of these neurons. In addition, postmortem studies have found high concentrations of organochlorine pesticides in the substantia nigra [21,23,24].
Animal studies have shown the involvement of organophosphates (OPs) in the development of PD. For example, chronic exposure to dichlorvos caused nigrostriatal dopaminergic degeneration and a 60–80% decrease in levels of tyrosine hydroxylase and dopamine in the striatum, while malathion increased the concentration of α-synuclein in the striatum. Moreover, OPs induce damage to the dopaminergic system through the production of ROS [24,25,26]. The pyrethroids cypermethrin and deltamethrin interfere with dopaminergic mechanisms involved in the production of dopamine, thereby decreasing the level of this neurotransmitter in the brain [27].
Several studies have demonstrated that paraquat is absorbed by the dopamine transporter, thereby resulting in toxicity and apoptosis due to oxidative stress [27,28,29]. Moreover, in an animal study, Drolet et al. (2009) reported that rotenone administration caused loss of striatal dopamine and accumulation of α-synuclein in the other dopaminergic neurons, in addition to the appearance of PD characteristics such as rigidity, postural instability, and bradykinesia [30].
Table 2. Pesticides associated with pathogenesis of PD.
Table 2. Pesticides associated with pathogenesis of PD.
Pesticide ClassificationType of PesticideRelationship with PDType of StudyReferences
OrganochlorinesDieldrinActed as dopaminergic toxin in mesencephalic cultures.Review[27]
Reduced brain dopamine levels, increased ROS in nigral dopaminergic neurons, inhibited mitochondrial oxidative phosphorylation, altered mitochondrial membrane potential, and caused cytochrome C release.Review[21]
There were increased concentrations of these insecticides in the substantia nigra, which may be directly related to reduced dopamine concentrationsPost mortem study[23]
LindaneThere were increased concentrations of these insecticides in the substantia nigra, which may be directly related to reduced dopamine concentrationsPost mortem study[23]
OthersThey were neurotoxic, produced oxidative stress, and damaged the dopaminergic system.Animal model[24]
OPsDichlorvosProduced nigrostriatal dopaminergic degeneration, reduced levels of striatal dopamine and tyrosine hydroxylase.Animal model[25]
MalathionIncreased levels of α-synuclein protein and mRNA in striatal tissueAnimal model[26]
OthersWere neurotoxic, and produced oxidative stress and damage to the dopaminergic systemAnimal model[24]
PyrethroidsCypermethrinInterfered with cholinergic and dopaminergic neurotransmission mechanismsReview[27]
DeltamethrinReduced dopamine levelsReview[27]
OthersRotenoneWere selectively toxic to dopaminergic neuronsHuman brain spheroid model from induced pluripotent stem cells[31]
Mitochondrial toxinCase-control studies[32,33]
Reduced tyrosine hydroxylase-positive neurons in the substantia nigra, induced loss of striatal dopamine, and accumulation of α-synuclein and polyubiquitin-positive aggregates in the remaining dopaminergic neuronsAnimal model[30]
ParaquatDamaged dopaminergic neurons due to oxidative stressCase-control studies[27]
Caused cellular toxicity due to oxidative stress to dopaminergic neurons.Animal model[28]
Led to loss of dopaminergic neurons due to oxidative stress.Review[29]

1.1.3. Dissociative Disorders

These disorders refer to mental disorders that involve disconnection and a lack of continuity of thoughts, memory, environments, actions, and identity. A person with a dissociative disorder is disconnected from reality in involuntary and unhealthy ways, leading to problems with daily functioning [34]. In the general population, the prevalence of dissociative disorders is 5% to 10%, while in psychiatric patients it is 10.2% to 41.4% [35]. Three main types of dissociative disorders are recognized: dissociative amnesia, dissociative identity disorder, and de-personalization/de-realization disorder [34].

Dissociative Amnesia

Dissociative amnesia (DA) is a disorder characterized by disruptions in the proper functioning of consciousness, memory, identity, and behavior. The affected person is unable to remember moments of their own life. In DA, there are alterations in brain sections such as the frontal cortex, hippocampus, temporal lobes (medial, right and left), hypothalamus, and thalamus. These structures are crucial in the processing of memory and emotional content, and they are activated in response to stress. However, certain neurotransmitters are also released, but in situations of minimal stress, the concentrations of dopamine, serotonin, acetylcholine, and norepinephrine are altered in the amygdala, hippocampus, and prefrontal cortex. Acute stress produces variations in levels of corticosterone, a hormone that regulates the release and activities of the aforementioned neurotransmitters and, under normal conditions, consolidates long-term memory. Consequently, changes in the action of corticosterone cause alterations in the activities of the different neurotransmitters. These changes are associated with an inability to remember events, the development of disruptive behaviors, and, ultimately, the development of DA [36,37].

Dissociative Identity Disorder (DID)

Formerly known as multiple personality disorder, it is a condition in which two or more different personalities coexist, with each one of them having its own criteria for perceiving and thinking about itself and the external environment. In this disease, there are serious changes in the way a person feels about himself, in addition to important alterations in behavior, memory, perception, cognition and functioning of sensorimotor [38].
Currently, it is more acceptable to refer to this condition as discontinuity in memory and identity. Dissociative identity disorder (DID) has the characteristic symptoms of other dissociative disorders (AD and de-personalization/de-realization). It is important to point out that for the diagnosis of DID, DA must be present. This explains the amnesia that the other personalities manifest. Patients with DID may present transient psychotic symptoms, e.g., hallucinations [39].

Depersonalization/De-Realization (DD)

This is a psychiatric condition characterized by permanent feelings of unreality about the outside world as well as self-detachment. Depersonalization is an experience in which the person affected does not control his thinking. Consequently, he feels alienated, distant, and unable to identify himself. In contrast, de-realization is the feeling of strangeness towards the outside world. Both experiences are related. However, the patient may suffer episodes of de-realization without having experienced de-personalization, and vice versa. Due to their inability to describe experiences clearly, these patients often resort to metaphors, and since they never lose contact with reality and are able to identify sensations during DD episodes, this disorder is considered a type of neurosis [40,41]. Depersonalization may be due to alterations in the levels of different neurotransmitters, for example, glutaminergic N-methyl-D-aspartate (NMDA) receptors distributed throughout the amygdala, hippocampus, and cerebral cortex. These neurotransmitters are involved in associative functions in long-term memory. In cholinergic overstimulation, the activation of these receptors induces the release of nitric oxide, which causes neurotoxicity and neuronal degeneration by interacting with the superoxide radical to form nitric superoxide [42,43].
The neurotoxicity of some types of pesticides affects the synthesis, release, absorption, and degradation of different neurotransmitters. The OPs affect the central nervous system by inhibiting AChE, which catalyzes the hydrolysis of ACh into choline and acetate. Because of AChE inhibition, an excessive accumulation of ACh occurs in the synaptic cleft, causing overstimulation of nicotinic and muscarinic receptors located both in the central nervous system and at the neuromuscular junction, hence the importance of the dose, exposure time, and severity of the poisoning [6,44] (Figure 2).
The overstimulation of muscarinic receptors results in a loss of integrity of the cholinergic pathways and generates neuronal death in brain regions such as the hypothalamus, thalamus, and basal anterior cerebral cortex [6]. Stimulation of muscarinic receptors causes miosis, urination, bradycardia, bronchorrhea, bronchospasm, emesis, and salivation [45].
Overactivation of the nicotinic receptor favors the influx of Ca2+ into the cell and promotes increased levels of reactive oxygen species (ROS), oxidative stress, and apoptosis [46]. In addition, the production of ROS in the mitochondria causes the release of cytochrome C, which in turn activates caspases 3 and 9, increasing the expression of apoptotic genes [47]. At the central nervous system level, nicotinic effects cause headaches, confusion, anxiety, ataxia, and seizures [45].
OPs also inhibit the esterase target of neuropathy, present in peripheral nerves, lymphocytes, and the brain, causing tardive polyneuropathy [48]. Conditions seen in subjects with tardive polyneuropathy include depression, psychosis, and impaired processing and problem-solving abilities [49].
A recent study sought to associate OP exposure with neurological disorders such as dementia, attention deficit hyperactivity disorder, Parkinson’s, cognitive development, chronic neuropsychiatric disorders, and autism. The authors presented evidence of a strong link between repeated exposure to OPs and neurodevelopmental, cognitive, and attention deficit disorders in children [46].

2. Discussion

Although the existing information on a possible relationship between the development of dissociative disorders and pesticide exposure is null, an association can be made between the characteristic symptoms of said disorders, particularly dementia and memory loss since there is evidence that the pesticides participate in the development of these symptoms, affecting different neurotransmitters or organs, and may represent a risk factor acting alone or in conjunction with other components such as stress, abuse, or a congenital disease related to the development of dissociative disorders.
The main alterations in different organs, organelles, and neurotransmitters due to pesticide exposure are discussed in Table 3. The mechanisms involved in these alterations are similar to the mechanisms that trigger characteristic symptoms of dissociative disorders, mainly amnesia and loss of memory.
One of the mechanisms involved is the one that induces rotenone by inhibiting the electron transport chain in the mitochondria, causing hyperphosphorylation of the Tau protein, the formation of β-amyloid peptides, and increased lipid peroxidation (causing oxidative stress). DDT also impairs the electron transport chain. [50,51,52,53].
Likewise, Souders et al. (2021) reported malformation of the nervous system, neurofibrillary tangles, neuroinflammation, and nerve fiber degeneration in neuronal cells of rats exposed to fipronil [54]. Moreover, Cam et al., (2018) have demonstrated that fipronil stimulated the production of amyloid peptides which constitute a characteristic abnormality in Alzheimer’s disease [55].
Pesticides such as dieldrin, rotenone, and paraquat induce apoptosis of dopaminergic neurons, thereby altering their proper functioning in the brain and resulting in neurodegenerative conditions such as Parkinson’s disease and/or Alzheimer’s disease [21].
OPs are AChE inhibitors that impair the cholinergic system and interrupt axonal transport and mitochondrial function, thereby triggering neurological disorders, e.g., memory loss [44,56]. OPs are distributed to all regions of the brain, including the hippocampus, the major region involved in learning and memory regulation. Organophosphate-oxons disrupt the development of the nervous system, glial cell proliferation, differentiation, and neural function [57]. Other evidence indicates that there is a gradual loss of neuronal cells in the amygdala in acute diisopropylfluorophosphate poisoning, with behavioral changes as the major consequence [58]. Constant memory deterioration is one of the most observed behavioral changes in people intoxicated with OPs [59].
Glyphosate, a broad-spectrum herbicide, causes oxidative stress-induced neuronal alteration [60].
A study by Nasuti et al. (2014) showed that early exposure to permethrin led to severe hippocampal lesions such as impairment of long-term memory and disruption of synaptic morphology [61]. Continued exposure to deltamethrin, a synthetic pyrethroid, led to apoptotic cell death in the hippocampus, endoplasmic reticulum stress, and decreased proliferation of the hippocampal precursor, all of which are associated with learning deficits [62].
It has been reported that chronic administration of chlorpyrifos significantly impaired learning, memory, and motor coordination [63]. Exposure to pesticides such as parathion, hexachlorocyclohexane, and aldrin resulted in an increased risk of dementia and the subsequent onset of Alzheimer’s disease [64]. Chronic exposure to OPs and organochlorines produces neurobehavioral effects [65].
Table 3. Organelles/organs/neurotransmitters altered by pesticides, and their association with dissociative disorders.
Table 3. Organelles/organs/neurotransmitters altered by pesticides, and their association with dissociative disorders.
Organelle/Organ/NeurotransmitterPesticideMechanismEffects Related to DA, DID and DDReference
MitochondriaRotenoneInhibition of the electron transport chainProduction of mitochondrial and neuronal ROS, resulting in neuroinflammation[52]
DDTAlteration oxidative phosphorylation
GABAFenilpirazol fipronilBlockage of ionotropic γ-aminobutyric acid (GABA) receptors in the central nervous systemCentral nervous system overexcitation, seizure, and death[54]
DopamineStimulation of the production of amyloid peptides Aβ42/Aβ43Alzheimer’s disease[55]
DopamineDieldrinCrossing of the blood-brain barrier, selective toxicity to dopaminergic neuronsApoptosis of dopaminergic neurons[21]
RotenoneMitochondrial toxicity due to production of ROS
ParaquatProduction of ROS when taken up by the dopamine transporter
AcetylcholineOPsAChE inhibitionAlteration of the cholinergic system[44]
Mitochondria/axonsDisruption of mitochondrial function and axonal transportNeurological disorders[56]
Cell membranesRotenoneExacerbation of lipid peroxidationOxidative stress[53]
MitochondriaGlyphosateLoss of the active site for oxidative phosphorylationOxidative stress and inhibition of oxidative phosphorylation[60]
HippocampalPermethrinHippocampal dysfunction and amygdala impairmentPanic disorder, alteration in the morphology of the hippocampus and attention deficit[61]
Hippocampal ERDeltamethrinApoptosis in SK-N-AS neuroblastoma cells, increased levels of C/EBP homologous protein, glucose-regulated protein 78 caspase-12, activated caspase-3, and decreased BrdU-positive cellsStress, learning deficits, and impaired hippocampal neurogenesis[62]
HippocampusParaquatAlteration of levels of the Wnt pathway genes in neural progenitor cellsOxidative stress and inhibition of cell viability and proliferation[66]
DopamineRotenoneAlteration of levels of the Wnt pathway genes in neural progenitor cellsChanges in locomotor behavior and alteration in gene expression in dopaminergic neurons[67]
BrainChlorpyrifoAChE inhibitionImpaired memory and motor function[63]
OPsAChE inhibitionBrain damage from cholinergic neuronal dysfunction and excitotoxicity[65]
Table 4 presents specific evidence of the association between pesticides and dissociative disorders.
In DA, there is an alteration in brain structures, with high levels of pesticides such as glufosinate ammonium accumulating in the brain, thereby affecting the central nervous system and producing alterations in adults [68]. Studies have shown that parathion causes alterations in cholinergic, serotonergic, and dopaminergic synaptic functions in brain regions. Changes in neurotransmitter systems alter memory-related functions and affect neural connections, thereby contributing to the formation of neurodevelopmental disorders [6,69,70].
Dissociative Identity Disorder (DID) is associated with behavioral changes, memory loss, and amnesia. Evidence for the link between these symptoms and pesticides, particularly OPs, was found in medical studies carried out on patients with prolonged pesticide exposure who manifested chronic changes in behavior such as personality alteration, decreased memory, anxiety, depression, nervousness, and incoordination [71,72]. García (2000) carried out a descriptive follow-up study of patients with a history of acute poisoning by OPs. The main symptoms found corresponded to changes in behavior, such as irritability, difficulty with concentration, depression, memory problems, and tiredness [73].
Finally, dieldrin is a GABA A receptor antagonist that has been shown to decrease the number of functional NMDA receptors in primary cultures of mouse cortical neurons. Since these receptors are involved in associative functions in long-term memory, a decrease in their activity produces symptoms of DD [43,74].
Table 4. Pesticides that modify neurological functions related to dissociative disorders.
Table 4. Pesticides that modify neurological functions related to dissociative disorders.
DisorderNeurological AlterationPesticideReference
DAAlteration in frontal cortex, temporal lobes and diencephalon. Changes in levels of dopamine, serotonin, ACh and norepinephrineGlufosinate ammonium
Parathion
[6,68]
DIDPeripheral neuropathy and behavioral disturbanceOPs[73]
DDIntracellular accumulation of calcium through stimulation of anti-N-methyl-D-aspartate (NMDA) receptors and ROS productionDieldrin
OPs
[43,74]

3. Conclusions

Exposure to different types of pesticides could be related to neurotransmitter, organelle, and effector organ dysfunction that triggers dissociative disorders. These types of disorders are becoming more frequent in human populations, as is the massive use of different pesticides; however, this review exposes the necessity to increase the number of prospective studies that evaluate the neurotoxic potential of these substances and their relationship with dissociative disorders in humans.
The information shown in this review suggests that exposure to organochlorines, OPs, pyrethroids, etc., produces different brain disorders such as Alzheimer’s disease and PD. At the same time, it opens the possibility of developing new lines of research focused on exposure to pesticides and dissociative disorders. This possibility could provide alternatives that contribute to the prevention and treatment of these disorders.
However, more research is necessary to link pesticide exposure to the pathophysiology of dissociative disorders in humans. In addition, a larger number of studies are required in subjects exposed to a single pesticide to associate its effects with the dysfunction of different neurotransmitters, organelles, and effector organs, since the analysis of the data in this review comes from studies performed mainly in animals.
Finally, the analysis of the data shows the relationship between pesticides and symptoms of dissociative disorders, not those resulting from pesticide exposure, and does not describe the molecular mechanisms involved.

Author Contributions

Conceptualization, C.A.F.-G.; validation, E.R.-U.; formal analysis, J.H.T.-J.; M.Z.R.-V. and D.R.-B.; investigation, C.A.F.-G.; writing—original draft preparation, E.R.-U. and J.S.-F.; writing—review and editing, C.A.F.-G. and E.D.T.-S.; visualization, J.S.-F.; supervision, J.S.-F.; project administration, E.D.T.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Data are available on request from the authors.

Acknowledgments

We thank the National Council of Humanities, Sciences and Technology (CONAHCYT) for the scholarship of the student C.A.F-G. for the development of a master’s degree in science at the Cienega University Center, University of Guadalajara.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. La Vanguardia Los Plaguicidas Provocan 200.000 Muertes al año. 2017. Available online: https://www.lavanguardia.com/natural/20170309/42701670609/plaguicidas-herbicidas-insecticidas-muertes-intoxicacion-onu.html (accessed on 2 August 2023).
  2. Marrero, S.; González, S.; Guevara, H.; Eblen, A. Evaluación de la exposición a organofosforados y carbamatos en traba-jadores de una comunidad agraria. Comunidad Salud 2017, 15, 30–41. Available online: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S1690-32932017000100005 (accessed on 2 August 2023).
  3. Robb, E.L.; Baker, M.B. Toxicidad Organofosforada; StatPearls Publishing: St. Petersburg, FL, USA, 2023. [Google Scholar]
  4. Vásquez, M.O. Intoxicación por organofosforados. Rev. Medica Sinerg. 2020, 5, e558. [Google Scholar] [CrossRef]
  5. Fernández, D.G.; Mancipe, L.C.; Fernández, D.C. Intoxicación por organofosforados. Rev. Med. 2010, 18, 84–92. [Google Scholar] [CrossRef] [Green Version]
  6. Morales Ovalles, Y.; Miranda de Contreras, L.; Di Bernardo Navas, M.L. Neurotoxicidad de los plaguicidas como agentes disruptores endocrinos: Una revisión. Rev. Inst. Nac. Hig. Rafael Rangel 2014, 45, 96–119. Available online: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0798-04772014000200007 (accessed on 25 February 2023).
  7. INFOCOP. La Demencia: Una Prioridad de Salud Pública, Según la OMS. 2018. Available online: http://www.infocop.es/view_article.asp?id=7204 (accessed on 2 August 2023).
  8. Moneo Troncoso, A.I.; Pérez Lancho, M.C. Demencias Corticales. Caracterización Psicoconductual y Neurobiológica. 2022. Available online: http://hdl.handle.net/10662/15661 (accessed on 2 August 2023).
  9. Rodríguez-Leyva, I.; Oliva-Barrios, J.E.; Cueli-Barcena, S.; Carrizales-Rodríguez, J.; Chi-Ahumada, E.; Jiménez-Capdeville, M.E. Demencia frontotemporal: Revisión y nuestro punto de vista. Rev. Mex. Neurocienc. 2019, 19. [Google Scholar] [CrossRef] [Green Version]
  10. Charro-Gajate, C.; Diéguez-Perdiguero, E.; González-Martínez, L.A. La Demencia Más Psiquiátrica: Demencia Frontotemporal, Variante Frontal. Psicogeriatría 2010, 2, 227–232. Available online: https://www.viguera.com/sepg/pdf/revista/0204/0204_0227_0232.pdf (accessed on 4 April 2023).
  11. Toloza-Ramírez, D.; Méndez-Orellana, C.; Martella, D. Diagnóstico neuropsicológico diferencial en enfermedad de Alzheimer y demencia frontotemporal: Una revisión sistemática cualitativa. Neurol. Perspect. 2021, 1, 82–97. [Google Scholar] [CrossRef]
  12. Iragorri, Á.M. Demencia Frontotemporal. Rev. Colomb. Psiquiatr. 2007, 36, 139–156. Available online: http://www.scielo.org.co/scielo.php?pid=S0034-74502007000500012&script=sci_arttext (accessed on 15 March 2023).
  13. Cano, M.L.; Fernández MD, R.; Fernández, A. Impacto del Cuidado de Pacientes Crónicos, en la Salud de las Personas Cuidadoras. En Calidad de Vida, Cuidadores e Intervención Para la Mejora de la Salud en el Envejecimiento; Asociación Universitaria de Educación y Psicología (ASUNIVEP), Servicio Andaluz de Salud (España), Andaluz, España. 2015, Volume III, pp. 355–359. Available online: https://www.formacionasunivep.com/files/publicaciones/calidad-vida-envejecimiento-vol3.pdf#page=356 (accessed on 17 March 2023).
  14. Snowden, J.S.; Neary, D.; Mann, D.M.A.; Goulding, P.J.; Testa, H.J. Progressive language disorder due to lobar atrophy. Ann. Neurol. 1992, 31, 174–183. [Google Scholar] [CrossRef]
  15. Mesulam, M.-M. Primary Progressive Aphasia—A Language-Based Dementia. N. Engl. J. Med. 2003, 349, 1535–1542. [Google Scholar] [CrossRef]
  16. Snowden, J.S.; Bathgate, D.; Varma, A.; Blackshaw, A.; Gibbons, Z.C.; Neary, D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J. Neurol. Neurosurg. Psychiatry 2001, 70, 323–332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Ortiz, G.G.; Moisés, F.P.P.; Macías-Islas, M.Á.; Jiménez-Gil, F.J.; Miranda-Díaz, A.G.; Flores-Alvarado, L.J.; Bitzer-Quintero, O.K. Toxicidad de plaguicidas y su asociación con la enfermedad de Parkinson. Arch. Neurocienc. 2011, 16, 33–39. Available online: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=30120 (accessed on 2 August 2023).
  18. Villate, A. Nuevos Aspectos de la Etiopatogénesis y Diagnostico de la Enfermedad de Parkinson (EP) y Futuras Dianas Tera-péuticas. 2019. Available online: https://addi.ehu.es/bitstream/handle/10810/31074/TFG_Villate_Castillo_Rev.pdf?sequence=1&isAllowed=y (accessed on 15 March 2023).
  19. Corrales, F.S. Enfermedad de Párkinson. Master’s Thesis, Universidad Oberta de Catalunya, Barcelona, Spain, 2018. [Google Scholar]
  20. Beltré Casado, J.; Tapia García, L. Sobrecarga del Cuidador de Pacientes con Enfermedades Neurodegenerativas, que Asisten a la Consulta de Neurología del Hospital Doctor Salvador Bienvenido Gautier. 2020. Available online: https://repositorio.unphu.edu.do/handle/123456789/3623 (accessed on 11 July 2023).
  21. Chin-Chan, M.; Navarro-Yepes, J.; Quintanilla-Vega, B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front. Cell. Neurosci. 2015, 9, 124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Braak, H.; Del Tredici, K.; Rüb, U.; de Vos, R.A.; Steur, E.N.J.; Braak, E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 2003, 24, 197–211. [Google Scholar] [CrossRef] [PubMed]
  23. Corrigan, F.M.; Wienburg, C.L.; Shore, R.F.; Daniel, S.E.; Mann, D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J. Toxicol. Environ. Health Part A 2000, 59, 229–234. [Google Scholar] [CrossRef]
  24. Quesada, C.M.S.; Rivera, D.A. Presencia de pesticidas en la dieta como factor de riesgo para el parkinson esporádico. Rev. Médica Univ. Costa Rica 2014, 7. [Google Scholar] [CrossRef] [Green Version]
  25. Bk, B.; Bal, A.; Kandimalla, R.J.; Gill, K.D. Nigrostriatal neuronal death following chronic dichlorvos exposure: Crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes. Mol. Brain 2010, 3, 35. [Google Scholar] [CrossRef]
  26. Mohammadzadeh, L.; Rahbardar, M.G.; Razavi, B.M.; Hosseinzadeh, H. Crocin Protects Malathion-Induced Striatal Biochemical Deficits by Inhibiting Apoptosis and Increasing α-Synuclein in Rats’ Striatum. J. Mol. Neurosci. 2022, 72, 983–993. [Google Scholar] [CrossRef]
  27. Baltazar, M.T.; Dinis-Oliveira, R.J.; de Lourdes Bastos, M.; Tsatsakis, A.M.; Duarte, J.A.; Carvalho, F. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach. Toxicol. Lett. 2014, 230, 85–103. [Google Scholar] [CrossRef]
  28. Rappold, P.M.; Cui, M.; Chesser, A.S.; Tibbett, J.; Grima, J.C.; Duan, L.; Sen, N.; Javitch, J.A.; Tieu, K. Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc. Natl. Acad. Sci. USA 2011, 108, 20766–20771. [Google Scholar] [CrossRef]
  29. Vaccari, C.; El Dib, R.; Gomaa, H.; Lopes, L.C.; De Camargo, J.L. Paraquat and Parkinson’s disease: A systematic review and meta-analysis of observational studies. J. Toxicol. Environ. Health Part B 2019, 22, 172–202. [Google Scholar] [CrossRef] [PubMed]
  30. Drolet, R.E.; Cannon, J.R.; Montero, L.; Greenamyre, J.T. Chronic rotenone exposure reproduces Parkinson’s disease gastrointestinal neuropathology. Neurobiol. Dis. 2009, 36, 96–102. [Google Scholar] [CrossRef] [PubMed]
  31. Pamies, D.; Block, K.; Lau, P.; Gribaldo, L.; Pardo, C.A.; Barreras, P.; Smirnova, L.; Wiersma, D.; Zhao, L.; Harris, G.; et al. Rotenone exerts developmental neurotoxicity in a human brain spheroid model. Toxicol. Appl. Pharmacol. 2018, 354, 101–114. [Google Scholar] [CrossRef]
  32. Dhillon, A.S.; Tarbutton, G.L.; Levin, J.L.; Plotkin, G.M.; Lowry, L.K.; Nalbone, J.T.; Shepherd, S. Pesticide/Environmental Exposures and Parkinson's Disease in East Texas. J. Agromed. 2008, 13, 37–48. [Google Scholar] [CrossRef] [PubMed]
  33. Tanner, C.M.; Kamel, F.; Ross, G.W.; Hoppin, J.A.; Goldman, S.M.; Korell, M.; Marras, C.; Bhudhikanok, G.S.; Kasten, M.; Chade, A.R.; et al. Rotenone, Paraquat, and Parkinson’s Disease. Environ. Health Perspect. 2011, 119, 866–872. [Google Scholar] [CrossRef] [Green Version]
  34. Domínguez, B.; Espejo Díaz, G.; Silverio, J.; Avilez, V. Mecanismos Subyacentes al Trastorno Orgánico. 2019. Available online: https://repositorio.unphu.edu.do/bitstream/handle/123456789/3577/La%20complejidad%20del%20cerebro-Facultad%20de%20Humanidades%20y%20educacion-Escuela%20de%20psicolog%c3%ada-Enero-Abril-2019-Volumen%20XVMecanis-mos%20subyacentes%20al%20trastorno%20org%c3%a1nico..pdf?sequence=1&isAllowed=y (accessed on 25 March 2023).
  35. Robles García, R.; Garibay Rico, S.E.; Páez Agráz, F. Evaluación de trastornos disociativos en población psiquiátrica mexicana: Prevalencia, comorbilidad y características psicométricas de la Escala de Experiencias Disociativas. Salud Ment. 2006, 29, 38–43. [Google Scholar]
  36. Schlozman, S.C.; Nonacs, R.M. Trastornos disociativos. In Tratado de Psiquiatría Clínica Massachusetts General Hospital, 2nd ed; Elsevier: Barcelona, Spain, 2017. [Google Scholar]
  37. Cuesta, C.; Cossini, F.C.; Politis, D.G. Las bases neurales de la Amnesia Disociativa (AD): Una revisión sistemática de la bibliografía. Vertex Rev. Argent. Psiquiatr. 2021, 32, 11–16. [Google Scholar] [CrossRef]
  38. Sarto, A.C.G.; Garrigós, N.S.; Chocán, N.B.; Valles, N.L.; Palacios, B.M.; Bueno, M.T.B. Trastorno de Identidad Disociativo. Rev. Sanit. Investig. 2022, 3, 75. Available online: https://dialnet.unirioja.es/servlet/articulo?codigo=8569905 (accessed on 4 April 2023).
  39. Rubio, J.C.; García, M.O. Trastornos disociativos. Med. Programa Form. Médica Contin. Acreditado 2019, 12, 4938–4946. [Google Scholar] [CrossRef]
  40. Alvarado, C.D. El trastorno de despersonalización y desrealización desde el punto de vista de la psicoterapia fenomenológica-existencial. Organización de un taller en el aula de Educación Infantil 5 Proyecto de Implementación del enfoque de Inteligencias Múltiples para la innovación educativa en la etapa infantil 11. Publicaciones Didácticas 2017, 86, 180–196. Available online: https://core.ac.uk/download/pdf/235855536.pdf (accessed on 7 April 2023).
  41. Yang, J.; Millman, L.S.M.; David, A.S.; Hunter, E.C. The Prevalence of Depersonalization-Derealization Disorder: A Systematic Review. J. Trauma Dissociation 2023, 24, 8–41. [Google Scholar] [CrossRef] [PubMed]
  42. Castillo, J.J.M. Adaptación y validación al castellano de la Escala de Despersonalización de Cambridge. Ph.D. Thesis, Universidad de Córdoba, Córdoba, Spain, 2008. [Google Scholar]
  43. Pinilla-Monsalve, G.D.; Manrique-Hernández, E.F.; Caballero-Carvajal, A.J.; Gómez-Rodríguez, E.; Marín-Hernández, L.R.; Portilla-Portillas, Á.; Sierra-Avendaño, J.A.; Prieto-Serrano, H.J.; Oviedo-Pastrana, D.F.; Gamboa-Toloza, N. Neurotoxicología de plaguicidas prevalentes en la región Andina Colombiana. Medicas UIS 2014, 27, 57–67. Available online: http://www.scielo.org.co/scielo.php?pid=S0121-03192014000300007&script=sci_arttext (accessed on 25 February 2023).
  44. Saborío Cervantes, I.E.; Mora Valverde, M.; Durán Monge, M.D.P. Intoxicación por organofosforados. Med. Leg. Costa Rica 2019, 36, 110–117. Available online: https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152019000100110 (accessed on 7 April 2023).
  45. Slavica, V.; Dubravko, B.; Milan, J. Acute organophosphate poisoning: 17 years of experience of the National Poison Control Center in Serbia. Toxicology 2018, 409, 73–79. [Google Scholar] [CrossRef]
  46. Jokanović, M.; Oleksak, P.; Kuca, K. Multiple neurological effects associated with exposure to organophosphorus pesticides in man. Toxicology 2023, 484, 153407. [Google Scholar] [CrossRef]
  47. Camacho-Pérez, M.R.; Covantes-Rosales, C.E.; Toledo-Ibarra, G.A.; Mercado-Salgado, U.; Ponce-Regalado, M.D.; Díaz-Resendiz, K.J.G.; Girón-Pérez, M.I. Organophosphorus Pesticides as Modulating Substances of Inflammation through the Cholinergic Pathway. Int. J. Mol. Sci. 2022, 23, 4523. [Google Scholar] [CrossRef]
  48. Narang, U.; Narang, P.; Gupta, O. Organophosphorus poisoning: A social calamity. J. Mahatma Gandhi Inst. Med. Sci. 2015, 20, 46. [Google Scholar] [CrossRef]
  49. Naughton, S.X.; Terry, A.V. Neurotoxicity in acute and repeated organophosphate exposure. Toxicology 2018, 408, 101–112. [Google Scholar] [CrossRef] [PubMed]
  50. Won, J.-H.; Park, S.; Hong, S.; Son, S.; Yu, J.-W. Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation. J. Biol. Chem. 2015, 290, 27425–27437. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Elmore, S.E.; La Merrill, M.A. Oxidative Phosphorylation Impairment by DDT and DDE. Front. Endocrinol. 2019, 10, 122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Tang, B.L. Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease. Toxics 2020, 8, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Avcı, B.; Günaydın, C.; Güvenç, T.; Yavuz, C.K.; Kuruca, N.; Bilge, S.S. Idebenone Ameliorates Rotenone-Induced Parkinson’s Disease in Rats Through Decreasing Lipid Peroxidation. Neurochem. Res. 2020, 46, 513–522. [Google Scholar] [CrossRef]
  54. Souders, C.L.; Rushin, A.; Sanchez, C.L.; Toth, D.; Adamovsky, O.; Martyniuk, C.J. Mitochondrial and transcriptome responses in rat dopaminergic neuronal cells following exposure to the insecticide fipronil. Neurotoxicology 2021, 85, 173–185. [Google Scholar] [CrossRef]
  55. Cam, M.; Durieu, E.; Bodin, M.; Manousopoulou, A.; Koslowski, S.; Vasylieva, N.; Barnych, B.; Hammock, B.D.; Bohl, B.; Koch, P.; et al. Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides. J. Alzheimer's Dis. 2018, 62, 1663–1681. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Moller, A.; Bauer, C.S.; Cohen, R.N.; Webster, C.P.; De Vos, K.J. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum. Mol. Genet. 2017, 26, 4668–4679. [Google Scholar] [CrossRef] [PubMed]
  57. Farkhondeh, T.; Mehrpour, O.; Forouzanfar, F.; Roshanravan, B.; Samarghandian, S. Oxidative stress and mitochondrial dysfunction in organophosphate pesticide-induced neurotoxicity and its amelioration: A review. Environ. Sci. Pollut. Res. 2020, 27, 24799–24814. [Google Scholar] [CrossRef]
  58. Sisó, S.; Hobson, B.A.; Harvey, D.J.; Bruun, D.A.; Rowland, D.J.; Garbow, J.R.; Lein, P.J. Editor’s Highlight: Spatiotemporal Progression and Remission of Lesions in the Rat Brain Following Acute Intoxication with Diisopropylfluorophosphate. Toxicol. Sci. 2017, 157, 330–341. [Google Scholar] [CrossRef] [Green Version]
  59. Chen, Y. Organophosphate-induced brain damage: Mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology 2012, 33, 391–400. [Google Scholar] [CrossRef]
  60. McCully, K.S. Environmental Pollution, Oxidative Stress and Thioretinaco Ozonide: Effects of Glyphosate, Fluoride and Electromagnetic Fields on Mitochondrial Dysfunction in Carcinogenesis, Atherogenesis and Aging. Ann. Clin. Lab. Sci. 2020, 50, 408–411. [Google Scholar] [PubMed]
  61. Nasuti, C.; Fattoretti, P.; Carloni, M.; Fedeli, D.; Ubaldi, M.; Ciccocioppo, R.; Gabbianelli, R. Neonatal exposure to permethrin pesticide causes lifelong fear and spatial learning deficits and alters hippocampal morphology of synapses. J. Neurodev. Disord. 2014, 6, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Hossain, M.M.; DiCicco-Bloom, E.; Richardson, J.R. Hippocampal ER Stress and Learning Deficits Following Repeated Pyrethroid Exposure. Toxicol. Sci. 2015, 143, 220–228. [Google Scholar] [CrossRef] [Green Version]
  63. Singh, S.; Prakash, A.; Kaur, S.; Ming, L.C.; Mani, V.; Majeed, A.B.A. The role of multifunctional drug therapy as an antidote to combat experimental subacute neurotoxicity induced by organophosphate pesticides. Environ. Toxicol. 2016, 31, 1017–1026. [Google Scholar] [CrossRef]
  64. Hayden, K.M.; Norton, M.C.; Darcey, D.; Ostbye, T.; Zandi, P.P.; Breitner, J.C.S.; Welsh-Bohmer, K.A. Occupational exposure to pesticides increases the risk of incident AD: The Cache County Study. Neurology 2010, 74, 1524–1530. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Androutsopoulos, V.P.; Hernandez, A.F.; Liesivuori, J.; Tsatsakis, A.M. A mechanistic overview of health associated effects of low levels of organochlorine and organophosphorous pesticides. Toxicology 2013, 307, 89–94. [Google Scholar] [CrossRef]
  66. Zhao, L.; Yan, M.; Wang, X.; Xiong, G.; Wu, C.; Wang, Z.; Zhou, Z.; Chang, X. Modification of Wnt signaling pathway on paraquat-induced inhibition of neural progenitor cell proliferation. Food Chem. Toxicol. 2018, 121, 311–325. [Google Scholar] [CrossRef]
  67. Stephano, F.; Nolte, S.; Hoffmann, J.; El-Kholy, S.; von Frieling, J.; Bruchhaus, I.; Fink, C.; Roeder, T. Impaired Wnt signaling in dopamine containing neurons is associated with pathogenesis in a rotenone triggered Drosophila Parkinson’s disease model. Sci. Rep. 2018, 8, 2372. [Google Scholar] [CrossRef] [Green Version]
  68. Apolo, S.G.; Garzón, A.O.; Lanchi, G.D.; Toledo, J.M.; Cherrez, P.J.; Ribera, K.E. Factores que incrementan la discapacidad de tipo mental en los trastornos del espectro autista. Medicina 2023, 12, 03. [Google Scholar] [CrossRef]
  69. Slotkin, T.A.; Levin, E.D.; Seidler, F.J. Developmental neurotoxicity of parathion: Progressive effects on serotonergic systems in adolescence and adulthood. Neurotoxicol. Teratol. 2009, 31, 11–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Levin, E.D.; Timofeeva, O.A.; Yang, L.; Petro, A.; Ryde, I.T.; Wrench, N.; Seidler, F.J.; Slotkin, T.A. Early postnatal parathion exposure in rats causes sex-selective cognitive impairment and neurotransmitter defects which emerge in aging. Behav. Brain Res. 2010, 208, 319–327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Jokanović, M. Neurotoxic effects of organophosphorus pesticides and possible association with neurodegenerative diseases in man: A review. Toxicology 2018, 410, 125–131. [Google Scholar] [CrossRef] [PubMed]
  72. de Plaguicidas, N.P.D.M. Memoria Congreso Nacional: Impacto de Plaguicidas en Ambiente, Salud Trabajo y Agricultura; Marena, Managua 1997; p. 490. ID: Lil-309487. Available online: https://pesquisa.bvsalud.org/portal/resource/pt/lil-309487 (accessed on 29 June 2023).
  73. Garcia, Y.D.C.L. Determinacion de Sintomas de Neurotoxicidad Secundaria a Intoxicacion por Plaguicidas Organofosforados, Universidad de San Carlos de Guatemala. 2020. Available online: https://biblioteca.medicina.usac.edu.gt/tesis/pre/2000/081.pdf (accessed on 11 July 2023).
  74. Briz, V.; Suñol, C. La Exposición Prolongada a Dieldrín Reduce la Funcionalidad de los Receptores NMDA y Metabotropicos de Glutamato de Tipo-I en Cultivos Primarios de Neuronas Corticales de Ratón. 2008. Available online: http://hdl.handle.net/10261/83406 (accessed on 29 June 2023).
Figure 1. Clinical variants of frontotemporal dementia. Affected areas and main symptoms of the clinical variants of frontotemporal dementia: Front variant, primary progressive aphasia, and semantic dementia. Created with Biorender.com.
Figure 1. Clinical variants of frontotemporal dementia. Affected areas and main symptoms of the clinical variants of frontotemporal dementia: Front variant, primary progressive aphasia, and semantic dementia. Created with Biorender.com.
Brainsci 13 01194 g001
Figure 2. Damage caused by OPs. some of the consequences of exposure to OPs such as cholinergic syndrome and serotonergic and dopaminergic damage could be related to the development of dissociative disorders. Created with Biorender.com.
Figure 2. Damage caused by OPs. some of the consequences of exposure to OPs such as cholinergic syndrome and serotonergic and dopaminergic damage could be related to the development of dissociative disorders. Created with Biorender.com.
Brainsci 13 01194 g002
Table 1. Clinical variants of FTD.
Table 1. Clinical variants of FTD.
VariantSymptomatologyAnatomical Lesion
Behavioral/frontalChanges in personality and behavior (loss of emotionality, increased consumption of sweet foods, lack of interest in activities previously carried out, and neglect of personal care)Bilateral orbitofrontal cortex
Primary progressive aphasiaNon-fluent aphasia, altered. expression, but preserved comprehension.Perisylvian area
Semantic dementiaFluent anomic aphasia with impaired comprehension and loss of meaning.Bilateral or left inferolateral temporal cortex
Modified from [12].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Flores-Gutierrez, C.A.; Torres-Sanchez, E.D.; Reyes-Uribe, E.; Torres-Jasso, J.H.; Reyna-Villela, M.Z.; Rojas-Bravo, D.; Salazar-Flores, J. The Association between Pesticide Exposure and the Development of Fronto-Temporal Dementia-Cum-Dissociative Disorders: A Review. Brain Sci. 2023, 13, 1194. https://doi.org/10.3390/brainsci13081194

AMA Style

Flores-Gutierrez CA, Torres-Sanchez ED, Reyes-Uribe E, Torres-Jasso JH, Reyna-Villela MZ, Rojas-Bravo D, Salazar-Flores J. The Association between Pesticide Exposure and the Development of Fronto-Temporal Dementia-Cum-Dissociative Disorders: A Review. Brain Sciences. 2023; 13(8):1194. https://doi.org/10.3390/brainsci13081194

Chicago/Turabian Style

Flores-Gutierrez, Carlos Alfonso, Erandis Dheni Torres-Sanchez, Emmanuel Reyes-Uribe, Juan Heriberto Torres-Jasso, Mireya Zoila Reyna-Villela, Daniel Rojas-Bravo, and Joel Salazar-Flores. 2023. "The Association between Pesticide Exposure and the Development of Fronto-Temporal Dementia-Cum-Dissociative Disorders: A Review" Brain Sciences 13, no. 8: 1194. https://doi.org/10.3390/brainsci13081194

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop